Despite recent advances in the treatment of multiple myeloma, the disease constantly relapses and is still considered as incurable. The current knowledge about the biological mechanisms underlying resistance to the different class of drugs in multiple myeloma remains poor. | The MYRACLE protocol study A multicentric observational prospective cohort study of patients with multiple myeloma